使用WHO国际疾病分类第11版统计的卒中发病率、病例病死率和死亡率:日内瓦卒中研究
这项基于人群的观察性队列研究利用瑞士卒中登记等数据,按ICD-11标准识别2018年1月1日至2019年12月31日日内瓦州首次卒中居民共1186例。年龄标化年发病率为127.0/100000,缺血性卒中为107.3/100000,ICD-11较ICD-10使缺血性卒中病例数增加18.3%。
要点
- ICD-11首次卒中年龄标化年发病率为127.0/100000(95%CI 119.8-134.3)。
- 30天病例病死率:脑出血32.5%,蛛网膜下腔出血17.2%,缺血性卒中10.8%。
- ICD-11较ICD-10使缺血性卒中病例数增加18.3%。
核心结论
- 在新的ICD-11临床放射学定义下,西欧人群缺血性卒中病例数较ICD-10增加18.3%。
- 未来研究将评估ICD-11对疾病管理所投入的人力、组织和经济需求的影响。
研究设计与样本
- 基于人群的观察性队列研究,利用瑞士卒中登记并补充医院记录、门诊病历和尸检资料。
- 纳入2018年1月1日至2019年12月31日瑞士日内瓦州符合ICD-11首次卒中标准的居民,共1186例首次卒中(75.8岁[四分位距63.4-84.5];571名女性[48.1%])。
主要发现
- 缺血性卒中患者中90.9%接受了MRI检查。
- 年龄标化至欧洲标准人群的首次卒中年度发病率为127.0/100000(95%CI 119.8-134.3);缺血性卒中为107.3/100000(100.7-114.0),脑出血为13.2/100000(10.9-15.5),蛛网膜下腔出血为6.0/100000(4.4-7.5),其中动脉瘤性蛛网膜下腔出血为3.1/100000(2.0-4.2)。
- 30天病例病死率脑出血为32.5%(95%CI 19.7-38.8),蛛网膜下腔出血为17.2%(6.6-27.9),缺血性卒中为10.8%(8.4-12.4)。
- 缺血性卒中发病率按ICD-11为107.3/100000(100.7-114.0),按ICD-10为90.4/100000(84.3-96.5)(排除有影像学梗死且症状持续<24小时的患者)。
- 与ICD-10相比,ICD-11使缺血性卒中病例数增加18.3%;仅由ICD-11识别而ICD-10未识别的缺血性卒中患者(即有脑部病灶且症状持续<24小时者)较同时符合两种标准的患者更年轻且入院时NIHSS评分更低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In the field of stroke epidemiology, one of the major advances in the recently implemented International Classification of Diseases, 11th revision (ICD-11) relates to the definition of ischemic stroke, which now includes events shorter than 24 hours when ischemia can be proven on brain imaging. However, data are scarce to ascertain the incidence of strokes of short duration with tissue evidence of ischemia. In this study, we determined the incidence, 30-day case fatality, and mortality rate of stroke in the Geneva population using the new ICD-11 criteria, taking advantage of the organization of stroke service in the area. METHODS: In this population-based observational cohort study, we used data from the Swiss Stroke Registry, supplemented by hospital records, outpatient medical files, and autopsy, to identify residents of the canton of Geneva, Switzerland, meeting the ICD-11 criteria for first-ever stroke, including ischemic strokes, nontraumatic intracerebral hemorrhage (ICH), or subarachnoid hemorrhage (SAH), from January 1, 2018, to December 31, 2019. RESULTS: We identified 1,186 first-ever strokes (75.8 years [interquartile range 63.4-84.5]; 571 women [48.1%]). MRI was performed in 90.9% of patients with ischemic strokes. The annual incidence of first-ever stroke, age-adjusted to the European Standard Population, was 127.0/100,000 (95% CI 119.8-134.3) (107.3 [100.7-114.0] for ischemic stroke, 13.2 [10.9-15.5] for ICH, and 6.0 [4.4-7.5] for SAH [3.1 {2.0-4.2} for aneurysmal SAH]). Overall, the 30-day case fatality was higher in ICH (32.5% [95% CI 19.7-38.8], compared with SAH (17.2% [6.6-27.9] and ischemic strokes 10.8% [8.4-12.4]). The incidence of ischemic stroke was 107.3 (100.7-114.0) according to ICD-11 and 90.4 (84.3-96.5) according to ICD-10 (excluding patients with radiologic infarct and symptoms lasting <24 hours). Compared with ICD-10, ICD-11 increased the number of ischemic stroke cases by 18.3%. Patients with ischemic strokes identified with ICD-11 but not under ICD-10 (i.e., patients with symptoms lasting <24 hours and a brain lesion) were younger and presented with a lower National Institutes of Health Stroke Scale (NIHSS) score on admission compared with those identified by ICD-10 and ICD-11. DISCUSSION: The new ICD-11 clinicoradiologic definition of ischemic stroke increased the number of ischemic stroke cases by 18.3% in our Western European population. Future studies will evaluate the impact of ICD-11 on the human, organizational, and economic needs allocated to the management of the disease.
引用
- Dirren E, Escribano Paredes JB, Klug J, et al. Stroke Incidence, Case Fatality, and Mortality Using the WHO International Classification of Diseases 11: The Geneva Stroke Study. Neurology. 2025. PMID: 39965170. doi:10.1212/WNL.0000000000213353
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。